Infection Risk Up in Month After CAR T-Cell Immunotherapy
Infection rates increase in patients with ALL aged ≤26 years in first month, then decrease at days 29 to 90
Outcomes Equal for AYA Hodgkin Therapy at Peds, Adult Centers
Treatment strategies differ, but outcomes equivalent among adolescent, young adult Hodgkin patients
1990 to 2017 Saw Increase in Prevalence, Incidence of Psoriasis
In addition, global burden of suffering related to psoriasis increased, with increases in YLDs, DALYs
Five-Day Course of Remdesivir Beneficial in Severe COVID-19
No significant difference seen in five-, 10-day course for severe COVID-19 without mechanical ventilation
Inequity Found in Access to Transplant With Universal Health Care
Patient factors including socioeconomic status account for much variation in kidney transplant access
Burden of Severe COVID-19 High in California, Washington State
Length of stay was 9.3 days for survivors; probability high for ICU admission, mortality
Multiple Sclerosis Tied to Higher Risk for CVD, Cerebrovascular Disease
MS associated with a 3.5-fold higher risk for mortality, 1.5-fold higher risk for cardiovascular mortality
Success More Than 50 Percent for Second Child With Fertility Treatment
Chances range from 51 to 88 percent depending on use of frozen versus fresh embryos
ASCO: Relugolix Superior to Leuprolide in Advanced Prostate Cancer
And, enzalutamide improves median overall survival in nonmetastatic, castration-resistant prostate cancer
Exposure to Urban Air Pollution May Up Risk of Multiple Sclerosis
Adjusted risk 29 percent higher among those residing in more urbanized areas
